v3.26.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Research and development expenses $ 20,532,670 $ 13,335,316
Acquisition-related costs (note 5) 3,679,618 440,340
General and administrative expenses 7,583,651 3,873,836
Operating Loss (31,795,939) (17,649,492)
Other (Expense) Income:    
Employee Retention Tax Credit 113,574  
Grant income 713,508 57,627
Interest expense (625,283) (4,138,301)
Interest income 136,233 361,632
Change in fair value of derivative liability   (313,772)
Change in fair value of Kineta merger holdback shares 1,590,949  
Loss on Kineta employee separation payments assumed from merger (185,019)  
Total Other Income (Expense) 1,743,962 (4,032,814)
Net Loss (30,051,977) (21,682,306)
Series A Preferred cash dividend (8,356) (2,089)
Deemed dividend on warrant modifications 0 (965,177)
Net Loss attributable to common stockholders $ (30,060,333) $ (22,649,572)
Net Loss per share, basic $ (0.63) $ (1.21)
Net Loss per share, diluted $ (0.63) $ (1.21)
Weighted-average shares outstanding, basic 47,927,196 18,662,690
Weighted-average shares outstanding, diluted 47,927,196 18,662,690

Source

10-K XBRL Zip